Vicarious Surgical (NYSE: RBOT) — Perfil da empresa, notícias e dados financeiros
Vicarious Surgical enhances robotic surgery with innovative technologies that integrate virtual reality for minimally invasive procedures.
Vicarious Surgical
Vicarious Surgical (NYSE:RBOT) is a pioneering company focused on enhancing the field of robotic surgery through innovative technologies that improve patient outcomes and reduce recovery times. By integrating virtual reality with human-like surgical robots, Vicarious Surgical is revolutionizing minimally invasive procedures, allowing for precision and dexterity beyond traditional methods. Their projects aim to redefine the standards of surgical care, making complex procedures safer and more accessible. Objectives include advancing their technological platform, expanding the range of addressable surgical procedures, and securing regulatory approvals to bring their solutions to a global market. The pursuit of excellence in surgical innovation drives their mission to improve healthcare delivery worldwide.
Resumo
Operações
Produtos e/ou serviços de Vicarious Surgical
- Robotic surgery system designed to offer minimally invasive surgical procedures with enhanced precision, flexibility, and control for a range of complex operations.
- Proprietary surgical robotic technology that combines virtual reality with human-like robotic arms, allowing surgeons an unprecedented level of accuracy and dexterity.
- Advanced virtual reality platforms for surgical training, offering immersive pre-operative planning and simulation tools to enhance surgical precision and patient outcomes.
- Compact, flexible robots with the ability to navigate the human body more easily than traditional rigid surgical systems, reducing patient recovery time and improving surgical outcomes.
- Development of single-use instruments and accessories optimized for use with their robotic system, ensuring sterility and performance for each procedure.
- AI and machine learning algorithms aimed at improving surgical efficiency, patient safety, and outcomes by analyzing data collected during surgeries to recommend procedural adjustments.
equipe executiva do Vicarious Surgical
- Stephen FromCEO & Director
- Adam David SachsCo-Founder, President & Director
- Sammy KhalifaCo-founder, CTO & Director
- Barry Stuart GreeneCo-founder & Chief Medical Officer
Principais indicadores financeiros
Resultados divulgados pela Vicarious Surgical, em USD.
- Cap. de mercado
- 107 mil
- Receita (TTM)
- 0
- P/L
- —
- LPA (diluído, TTM)
- -6.6
- Dividend yield
- —
- Margem de lucro
- 0.0%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 0 | -51 mi | -50,2 mi | |
| 0 | -66,6 mi | -63,2 mi | |
| 0 | -80,7 mi | -71,1 mi | |
| 0 | -80,1 mi | 5,2 mi |